Company

Cardiol Therapeutics Inc.

Headquarters: Oakville, ON, Canada

CEO: Mr. David G. Elsley M.B.A., MBA

TSX: CRDL -0.37%

Market Cap

C$186.3 Million

CAD as of July 1, 2024

US$135.6 Million

Market Cap History

Cardiol Therapeutics Inc. market capitalization over time

Evolution of Cardiol Therapeutics Inc. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Cardiol Therapeutics Inc.

Detailed Description

Cardiol Therapeutics Inc., a clinical-stage biotechnology company, focuses on the research and development of anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, an ultra-pure and high concentration cannabidiol oral formulation for the treatment of in hospitalized COVID-19 patients with a prior history of risk factors for CVD; and has completed phase I clinical trials for the treatment of acute myocarditis and other inflammatory heart disease. The company is also developing a proprietary subcutaneous formulation of cannabidiol to achieve higher bioavailability for the treatment chronic heart failure. In addition, it develops proprietary nanotechnology to enable the distribution of water insoluble drugs within the blood circulation, enhance pharmacokinetics, and facilitate drug accumulation in the failing heart. Cardiol Therapeutics Inc. was incorporated in 2017 and is headquartered in Oakville, Canada.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Cardiol Therapeutics Inc. has the following listings and related stock indices.


Stock: TSX: CRDL wb_incandescent

Stock: FSX: CT9 wb_incandescent

Stock: NASDAQ: CRDL wb_incandescent

Stock: OTC: CRTPF wb_incandescent

Details

Headquarters:

2265 Upper Middle Road East

Suite 602

Oakville, ON L6H 0G5

Canada

Phone: 289 910 0850